For Cancer Drugs With China-Only Data, US FDA Leaves Door Open Just A Crack

 
• By Sue Sutter
Door crack
The US door is cracked ever so slightly for cancer drugs developed only in China. • Source: Alamy

More from US FDA Performance Tracker

More from Regulatory Trackers